Objectives
Distinguished Faculty
Educational Programs
Statement of Need
Contact and Membership
Find a Clinician
SpeakerReady Slide Lecture Guide
Clinician Challenge
Conference Calendar
Refer-a-Colleague
Literature
Resources
See how your answers relate to your colleagues'.
Which below medication is currently in Phase 3 clinical development for the treatment of NASH?
a. Tirzepatide
b. Resmetirom
c. Glimepiride
d. None of the above
Submit
